Additional lead improves defibrillation efficacy with an abdominal 'hot can' electrode system

Left Bundle Branch Area Pacing From a Femoral Approach in a Patient Without Superior Access

Limited venous access and lateral left ventricular scar are impediments to traditional cardiac resynchronization therapy. We present a case where placement of an implantable cardioverter-defibrillator from a femoral approach while using left bundle branch area pacing led to clinical improvement. (Level of Difficulty: Intermediate.).

Advantage of four-electrode over two-electrode defibrillators

Defibrillation is the standard clinical treatment used to stop ventricular fibrillation. An electrical device delivers a controlled amount of electrical energy via a pair of electrodes in order to reestablish a normal heart rate. We propose a technique that is a combination of biphasic shocks applied with a four-electrode system rather than the standard two-electrode system. We use a numerical model of a one-dimensional ring of cardiac tissue in order to test and evaluate the benefit of this technique. We compare three different shock protocols, namely a monophasic and two types of biphasic shocks. The results obtained by using a four-electrode system are compared quantitatively with those obtained with the standard two-electrode system. We find that a huge reduction in defibrillation threshold is achieved with the four-electrode system. For the most efficient protocol (asymmetric biphasic), we obtain a reduction in excess of 80% in the energy required for a defibrillation success rate of 90%. The mechanisms of successful defibrillation are also analyzed. This reveals that the advantage of asymmetric biphasic shocks with four electrodes lies in the duration of the cathodal and anodal phase of the shock.

The Strength-Duration Relationship of Monophasic Waveforms with Varying Capacitance Sizes in External Defibrillation

The shape of the shock waveform influences defibrillation efficacy. However, the optimal combination between capacitance size and truncation/tilt which can determine monophasic waveform's shape, has not been determined for external defibrillation. The purpose of this study was to assess the effects of varying capacitance and tilt on external defibrillation using exponential monophasic waveforms. In a pig model of external defibrillation (n = 10, 30 +/- 6 kg), nine exponential monophasic waveforms combining three capacitance values (30 microF, 60 microF, and 120 microF) and three tilt values (55%, 75%, and 95%) were tested randomly. The energy and leading edge voltage at 50% defibrillation success (E50 and V50) were used to evaluate defibrillation efficacy. E50 and V50 were determined by the Bayesian technique. The lowest stored E50 for the 30microF, 60 microF, and 120 microF waveforms were 90 +/- 12 J (95% tilt), 106 +/- 45 J (55% tilt), and 107 +/- 52 J (75% tilt), respectively. The lowest V50 for the 30 microF, 60 microF, and 120 microF waveforms were 2,439 +/- 166 V (95% tilt), 1,849 +/- 375 V (55% tilt), and 1,301 +/- 322 V (75% tilt), respectively. The average current at external defibrillation threshold demonstrated a strength versus pulse duration relationship similar to that seen with pacing. Reducing capacitance has the same effect as truncating the waveform. The E50 is more sensitive to tilt values changes in larger capacitance waveforms. This study suggests that the optimal combination between capacitance and tilt may be 120 microF and 55%-75% for external defibrillation.

Defibrillator implantation via the iliac vein

We describe a 23-year-old patient with idiopathic dilated cardiomyopathy in whom an implantable cardioverter defibrillator was implanted via the right external iliac vein. Addition of a subcutaneous patch was required to obtain an adequate safety margin for defibrillation.

Biventricular shocking leads improve defibrillation efficacy

INTRODUCTION

A single lead active can configuration has been widely used in patients with life-threatening ventricular arrhythmias. Occasionally, however, such a defibrillation lead configuration may not achieve adequate defibrillation threshold (DFT). The purpose of this study was to determine whether addition of a left ventricular (LV) lead can improve defibrillation efficacy.

METHODS AND RESULTS

Three transvenous defibrillation leads (8.3-French with a 5-cm long unipolar coil) were placed in the right ventricle (RV), LV, and superior vena cava (SVC), along with an active can (92 cm2) in the left subpectoral area. The DFT stored energy of seven combinations of these defibrillation leads were compared in a pig ventricular fibrillation model using a biphasic defibrillation waveform (125 microF, 6.5/3.5 msec). A biventricular leads active can configuration in which the RV and LV leads were of the same polarity reduced the DFT stored energy by approximately 35% when compared to a single RV lead active can configuration (9.6 +/- 3.0 J vs 15.0 +/- 7.2 J, respectively, P = 0.02). Moreover, adding a SVC lead further reduced the DFT energy (8.4 +/- 3.3 J).

CONCLUSION

A biventricular leads active can configuration can significantly improve defibrillation efficacy as compared to a single lead active can configuration. In such a defibrillation lead configuration, the polarity of RV and LV leads should be the same.

Technologic advances in implantable cardioverter defibrillators

Multiple technologic advances in the implantable cardioverter defibrillator (ICD) have resulted in smaller size, easier implantation, and improved detection, therapy, and stored diagnostic information. Advanced dual-chamber ICDs are currently available that allow dual-chamber rate-responsive pacing with mode switching, enhanced detection algorithms, antitachycardia pacing, low-energy cardioversion, high-energy shocks, and extensive diagnostics. Based on improvements in lead systems and improved energy waveforms, almost all devices are being implanted with nonthoracotomy leads in the pectoralis area. The results of recent clinical trials have expanded indications for the ICD for primary and secondary prevention of sudden cardiac death. With advances in capacitor and battery technology coupled with improved lead systems and waveform resulting in lower defibrillation thresholds, it is likely that lower-output, smaller devices will be developed. In the future, ICDs may have expanded indications and may incorporate physiologic sensors to access hemodynamic significance of arrhythmias and algorithms for prediction and prevention of cardiac arrhythmias.